Presbyterian Healthcare Services, University of New Mexico, Albuquerque, NM, USA.
Thromb Res. 2013 Nov;132(5):520-6. doi: 10.1016/j.thromres.2013.08.013. Epub 2013 Aug 28.
Medically ill, hospitalized patients are at increased risk for venous thromboembolism (VTE) after discharge. This study aimed to examine thromboprophylaxis patterns, risk factors, and post-discharge outcomes.
This was a retrospective claims analysis involving administrative claims data and in-patient data abstracted from a sample of hospital charts. Patients aged ≥ 40 years hospitalized for ≥ 2 days for nonsurgical reasons between 2005 and 2009 were included. Hospital chart data were abstracted for a random sample of patients without evidence of anticoagulant use at 30 days post-discharge. The combined data determined whether in-patient thromboprophylaxis (anticoagulant or mechanical prophylaxis) reduces risk of VTE at 90 days post-discharge. Hazard ratios (HR) and odds ratios (OR) were calculated using Cox proportional hazard models and logistic regression.
Of 141,628 patients in the claims analysis, 3.9% received anticoagulants (3.6% warfarin). VTE, rehospitalization, and mortality rates were 1.9%, 17.2%, and 6.2%, respectively. The strongest predictors of post-discharge VTE were history of VTE (HR=4.0, 95% confidence interval [CI]: 3.3-4.8), and rehospitalization (HR=3.9, 95% CI: 3.6-4.3). Of 504 medical charts, 209 (41.5%) reported in-patient thromboprophylaxis. There was no statistically significant difference in post-discharge VTE rates between patients who did and did not receive in-patient thromboprophylaxis. All-cause mortality was greater among patients without use of VTE prophylaxis.
Utilization rates of in-hospital and post-discharge VTE prophylaxis were low. In-hospital VTE prophylaxis did not reduce the risk of post-discharge VTE in the absence of post-discharge anticoagulation. Combined in-patient and post-discharge thromboprophylaxis lowered the odds of short-term, all-cause post-discharge mortality.
患有疾病的住院患者在出院后发生静脉血栓栓塞症(VTE)的风险增加。本研究旨在研究血栓预防的模式、风险因素和出院后结局。
这是一项回顾性的理赔分析,涉及行政理赔数据和从医院病历中抽取的住院数据。纳入 2005 年至 2009 年期间因非手术原因住院≥2 天且年龄≥40 岁的患者。对无出院后 30 天内使用抗凝剂证据的患者进行随机样本的病历数据抽取。综合数据确定住院期间(抗凝或机械预防)是否降低出院后 90 天内 VTE 的风险。使用 Cox 比例风险模型和逻辑回归计算危险比(HR)和优势比(OR)。
在理赔分析中,有 141628 名患者,3.9%接受了抗凝剂(3.6%华法林)。VTE、再住院和死亡率分别为 1.9%、17.2%和 6.2%。出院后 VTE 的最强预测因素是 VTE 病史(HR=4.0,95%置信区间[CI]:3.3-4.8)和再住院(HR=3.9,95% CI:3.6-4.3)。在 504 份病历中,有 209 份(41.5%)报告了住院期间的血栓预防。接受和未接受住院期间血栓预防的患者在出院后 VTE 发生率方面无统计学差异。未使用 VTE 预防措施的患者全因死亡率更高。
院内和出院后 VTE 预防的使用率较低。在没有出院后抗凝的情况下,住院 VTE 预防并不能降低出院后 VTE 的风险。住院和出院后联合血栓预防降低了短期全因出院后死亡率的几率。